Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo (original) (raw)

This study examines the differential effects of escitalopram, citalopram, and placebo on symptom severity and overall quality of life in patients with panic disorder. Findings indicate that while both SSRIs are effective in reducing panic frequency, they significantly differ in their impacts on quality of life, particularly highlighting the role of various anxiety and coping mechanisms. The results suggest the importance of utilizing comprehensive measures of both symptom severity and quality of life when evaluating treatment efficacy in panic disorder.